These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 21277864)
1. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels. Reis GM; Ramos MA; Pacheco Dda F; Klein A; Perez AC; Duarte ID Life Sci; 2011 Apr; 88(15-16):653-7. PubMed ID: 21277864 [TBL] [Abstract][Full Text] [Related]
2. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide. Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231 [TBL] [Abstract][Full Text] [Related]
3. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors. Romero TR; Pacheco Dda F; Duarte ID Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446 [TBL] [Abstract][Full Text] [Related]
4. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system. Romero TR; Resende LC; Guzzo LS; Duarte ID Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980 [TBL] [Abstract][Full Text] [Related]
5. α Romero TRL; Miranda E Castor MG; Parrella C; Piscitelli F; Di Marzo V; Duarte IDG Pharmacol Rep; 2020 Feb; 72(1):96-103. PubMed ID: 32016857 [TBL] [Abstract][Full Text] [Related]
7. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level. Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592 [TBL] [Abstract][Full Text] [Related]
8. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by ketamine. Romero TR; Duarte ID Vet Anaesth Analg; 2013 Jul; 40(4):419-24. PubMed ID: 23490455 [TBL] [Abstract][Full Text] [Related]
9. Study of the involvement of K+ channels in the peripheral antinociception of the kappa-opioid receptor agonist bremazocine. Amarante LH; Alves DP; Duarte ID Eur J Pharmacol; 2004 Jun; 494(2-3):155-60. PubMed ID: 15212969 [TBL] [Abstract][Full Text] [Related]
10. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice. Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355 [TBL] [Abstract][Full Text] [Related]
11. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis. Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532 [TBL] [Abstract][Full Text] [Related]
12. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by the alpha(2)-adrenoceptor agonist xylazine. Romero TR; Duarte ID J Pharmacol Sci; 2009 Dec; 111(4):323-7. PubMed ID: 20019444 [TBL] [Abstract][Full Text] [Related]
13. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation. Alves DP; Tatsuo MA; Leite R; Duarte ID Life Sci; 2004 Apr; 74(20):2577-91. PubMed ID: 15010267 [TBL] [Abstract][Full Text] [Related]
14. Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels. Reis GM; Duarte ID Br J Pharmacol; 2006 Nov; 149(6):733-9. PubMed ID: 17016510 [TBL] [Abstract][Full Text] [Related]
15. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP. Alves DP; Soares AC; Francischi JN; Castro MS; Perez AC; Duarte ID Eur J Pharmacol; 2004 Apr; 489(1-2):59-65. PubMed ID: 15063156 [TBL] [Abstract][Full Text] [Related]
16. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors. da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844 [TBL] [Abstract][Full Text] [Related]
17. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine. Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851 [TBL] [Abstract][Full Text] [Related]
18. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes. Mato S; Alberdi E; Ledent C; Watanabe M; Matute C Glia; 2009 Feb; 57(3):295-306. PubMed ID: 18814177 [TBL] [Abstract][Full Text] [Related]
19. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Haller VL; Stevens DL; Welch SP Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion. da Veiga MA; Fonseca Bloise F; Costa-E-Sousa RH; Souza LL; Almeida NA; Oliveira KJ; Pazos-Moura CC J Endocrinol; 2008 Nov; 199(2):235-42. PubMed ID: 18755884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]